The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index, and 2 are not checked yet.
Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53
Open accessAbstract
The tumor suppressor protein p53 is frequently inactivated in tumors. It functions as a transcriptional activator as well as a repressor for a number of viral and cellular promoters transcribed by RNA polymerase II (Pol II) and by RNA Pol III. Moreover, it appears that p53 also suppresses RNA Pol I transcription. In this study, we examined the molecular mechanism of Pol I transcriptional inhibition by p53. We show that wild-type, but not mutant, p53 can repress Pol I transcription from a human rRNA gene promoter in cotransfection assays. Furthermore, we show that recombinant p53 inhibits rRNA transcription in a cell-free transcription system. In agreement with these results, p53-null epithelial cells display an increased Pol I transcriptional activity compared to that of epithelial cells that express p53. However, both cell lines display comparable Pol I factor protein levels. Our biochemical analysis shows that p53 prevents the interaction between SL1 and UBF. Protein-protein interaction assays indicate that p53 binds to SL1, and this interaction is mostly mediated by direct contacts with TATA-binding protein and TAF(I)110. Moreover, template commitment assays show that while the formation of a UBF-SL1 complex can partially relieve the inhibition of transcription, only the assembly of a UBF-SL1-Pol I initiation complex on the rDNA promoter confers substantial protection against p53 inhibition. In summary, our results suggest that p53 represses RNA Pol I transcription by directly interfering with the assembly of a productive transcriptional machinery on the rRNA promoter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Induction of p53 leads to downregulation of rRNA genes212, 213 and of genes that are required for import and export of ribosomal proteins from the nucleus.214”
From Census and evaluation of p53 target genes (2017) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 3×
“Plasmids for the expression of glutathione Stransferase (GST) fusion human p53 fragments, pGThp53N ( 1-160 ), pGThp53C1 (160-318), pGThp53C2 (318-393), and pGThp53C (160-393), have been described previously (24).”
Backgroundp53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A. M., Jarosz, D., Friedman, P. N., Prives, C. L., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
[36] Eukaryotic gene transcription with purified components
Dignam, J. D., Martin, P. L., Shastry, B. S., & Roeder, R. G. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)01039-3 · Cited by 963
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J. A., Horikoshi, N., Weinmann, R. S., Levine, A. J., & Shenk, T. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R. D., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 289
Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop
He, X., Li, Y., Dai, M., & Sun, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7479 · Cited by 73
The impact of ribosome biogenesis in cancer: from proliferation to metastasis
Hwang, S.-P., & Denicourt, C. (2024) · NAR Cancer · doi:10.1093/narcan/zcae017 · Cited by 78
Shimono, K., Shimono, Y., Shimokata, K., Ishiguro, N., & Takahashi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507356200 · Cited by 66
Feedback Regulation of c-Myc by Ribosomal Protein L11
Dai, M., Sears, R. C., & Lu, H. (2007) · Cell Cycle · doi:10.4161/cc.6.22.4895 · Cited by 75
Kong, R., Zhang, L., Hu, L., Peng, Q., Han, W., Du, X., & Ke, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173393 · Cited by 67
Ray, S., Panova, T. B., Miller, G., Volkov, A., Porter, A. C. G., Russell, J., Panov, K. I., & Zomerdijk, J. C. B. M. (2013) · Nature Communications · doi:10.1038/ncomms2599 · Cited by 64
Zhong, S., Zhang, C., & Johnson, D. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5119-5129.2004 · Cited by 65
Regulation of Ribosomal Gene Expression in Cancer
Nguyen, L. X. T., Raval, A., Garcia, J. S., & Mitchell, B. S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24854 · Cited by 62
Identification of DHX33 as a Mediator of rRNA Synthesis and Cell Growth
Zhang, Y., Forys, J. T., Miceli, A. P., Gwinn, A. S., & Weber, J. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05832-11 · Cited by 62
Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma
Williamson, D. S., Lu, Y., Fang, C., Pritchard‐Jones, K., & SHIPLEY, J. M. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20347 · Cited by 63
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
Brighenti, E., Treré, D., & Derenzini, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5775 · Cited by 66
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status
Derenzini, M., Ceccarelli, C., Santini, D., Taffurelli, M., & Treré, D. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015917 · Cited by 62
Contribution of theBOP1 gene, located on 8q24, to colorectal tumorigenesis
Killian, A., Sarafan‐Vasseur, N., Sesboüé, R., Pessot, F. L., Blanchard, F., Lamy, A., Laurent, M., Flaman, J., & Frébourg, T. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20351 · Cited by 61
40 Years of Research Put p53 in Translation
Marcel, V., Long, F. N. V., & Diaz, J. (2018) · Cancers · doi:10.3390/cancers10050152 · Cited by 61
Velletri, T., Huang, Y., Wang, Y., Li, Q., Hu, M., Xie, N., Yang, Q., Chen, Q., Chen, Q., Shou, P., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0590-4 · Cited by 60
RNA Polymerases I and III in development and disease
Watt, K. E. N., Macintosh, J., Bernard, G., & Trainor, P. A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.027 · Cited by 62
Translational Control during Cellular Senescence
Payea, M. J., Anerillas, C., Tharakan, R., & Gorospe, M. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00512-20 · Cited by 56
Emerging roles of nucleolar and ribosomal proteins in cancer, development, and aging
Takada, H., & Kurisaki, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1984-1 · Cited by 58
Savva, L., & Georgiades, S. N. (2021) · Molecules · doi:10.3390/molecules26040841 · Cited by 57
Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy
Vlatković, N., Boyd, M. T., & Rubbi, C. P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1361-x · Cited by 54
Biological stoichiometry of tumor dynamics: Mathematical models and analysis
Kuang, Y., Nagy, J. D., & Elser, J. J. (2004) · Discrete and Continuous Dynamical Systems - B · doi:10.3934/dcdsb.2004.4.221 · Cited by 53
Targeting the nucleolus for cancer-specific activation of p53
Drygin, D., O’Brien, S., Hannan, R. D., McArthur, G. A., & Hoff, D. D. V. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.08.012 · Cited by 52
Anderson, S. J., Sikes, M. L., Zhang, Y., French, S. L., Salgia, S., Beyer, A. L., Nomura, M., & Schneider, D. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202101 · Cited by 51
The Role of TCOF1 Gene in Health and Disease: Beyond Treacher Collins Syndrome
Grzanka, M., & Piekiełko‐Witkowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052482 · Cited by 52
Yang, L., Song, T., Chen, L., Kabra, N., Zheng, H., Koomen, J. M., Seto, E., & Chen, J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00476-13 · Cited by 54
Montanaro, L., Mazzini, G., Barbieri, S., Vici, M., Nardi-Pantoli, A., Govoni, M., Donati, G., Treré, D., & Derenzini, M. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00448.x · Cited by 50
Cisterna, B., & Biggiogera, M. (2010) · International review of cytology · doi:10.1016/s1937-6448(10)84002-x · Cited by 48
Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression
O’Farrell, T. J., Ghosh, P., Dobashi, N., Sasaki, C. Y., & Longo, D. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3639 · Cited by 48
Putative involvement of the histone acetyltransferase Tip60 in ribosomal gene transcription
Halkidou, K. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh296 · Cited by 51
Direct Regulation of rRNA Transcription by Fibroblast Growth Factor 2
Sheng, Z., Liang, Y., Lin, C.-Y., Comai, L., & Chirico, W. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9419-9426.2005 · Cited by 48
Self-citationMeraner, J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl101 · Cited by 48
Song, T., Yang, L., Kabra, N., Chen, L., Koomen, J. M., Haura, E. B., & Chen, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470302 · Cited by 48
Dissecting microregulation of a master regulatory network
Sinha, A. U., Kaimal, V., Chen, J., & Jegga, A. G. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-88 · Cited by 44
High levels of TopBP1 induce ATR-dependent shut-down of rRNA transcription and nucleolar segregation
Sokka, M., Rilla, K. J., Miinalainen, I., Pospiech, H., & Syväoja, J. E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv371 · Cited by 45
ZNF76, a Novel Transcriptional Repressor Targeting TATA-binding Protein, Is Modulated by Sumoylation
Zheng, G., & Yang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407287200 · Cited by 45
Nucleolar repression facilitates initiation and maintenance of senescence
Yang, L., Song, T., Chen, L., Soliman, H. H., & Chen, J. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1100777 · Cited by 44
How Cancer Exploits Ribosomal RNA Biogenesis: A Journey beyond the Boundaries of rRNA Transcription
Gaviraghi, M., Vivori, C., & Tonon, G. (2019) · Cells · doi:10.3390/cells8091098 · Cited by 46
A Non-Tumor Suppressor Role for Basal p19ARF in Maintaining Nucleolar Structure and Function
Apicelli, A. J., Maggi, L. B., Hirbe, A. C., Miceli, A. P., Olanich, M. E., Winkeler, C. L., Saporita, A. J., Kuchenreuther, M., Sanchez, J., Weilbaecher, K. N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-07 · Cited by 41
Reactive nucleolar and Cajal body responses to proteasome inhibition in sensory ganglion neurons
Palanca, A., Casafont, Í., Berciano, M. T., & Lafarga, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.016 · Cited by 37
Biological Stoichiometry: An Ecological Perspective on Tumor Dynamics
Elser, J. J., Nagy, J. D., & Kuang, Y. (2003) · BioScience · doi:10.1641/0006-3568(2003)053[1112:bsaepo]2.0.co;2 · Cited by 37
Hoogeveen, A. T., Rossetti, S., Stoyanova, V., Schonkeren, J. J. M., Fenaroli, A., Schiaffonati, L., van Unen, L., & Sacchi, N. (2002) · Oncogene · doi:10.1038/sj.onc.1205882 · Cited by 37
Gridasova, A. A., & Henry, R. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3247-3260.2005 · Cited by 39
The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment
Li, H.-X., He, Y.-M., Jing, F., Guo, M., Zeng, C., Yan, P., Xu, Y., Qin, G., & Teng, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06473-8 · Cited by 40
Eberhard, R., Stergiou, L., Hofmann, E. R., Hofmann, J., Haenni, S., Teo, Y., Furger, A., & Hengartner, M. O. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003943 · Cited by 35
Hamdane, N., Herdman, C., Mars, J.-C., Stefanovsky, V. Y., Tremblay, M. G., & Moss, T. (2015) · Oncotarget · doi:10.18632/oncotarget.4823 · Cited by 35
BRCA1 Protein and Nucleolin Colocalize in Breast Carcinoma Tissue and Cancer Cell Lines
Tulchin, N., Chambon, M., Juan, G., DIKMAN, S. H., Strauchen, J. A., Ornstein, L., Billack, B., Woods, N. T., & Monteiro, Á. N. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.081063 · Cited by 35
Smirnov, E., Chmúrčiaková, N., & Cmarko, D. (2021) · Cells · doi:10.3390/cells10123452 · Cited by 37
Reňák, D., Gibalová, A., ŠOLCOVÁ, K., & Honys, D. (2013) · Plant Cell & Environment · doi:10.1111/pce.12186 · Cited by 35
Effective targeting of RNA polymerase I in treatment‐resistant prostate cancer
Low, J., Sirajuddin, P., Moubarek, M. S., Agarwal, S., Rege, A., Güner, G., Liu, H., Yang, Z., Marzo, A. M. D., Bieberich, C. J., et al. (2019) · The Prostate · doi:10.1002/pros.23909 · Cited by 36
Karni-Schmidt, O., Zupnick, A., Castillo, M., Ahmed, A., Matos, T., Bouvet, P., Cordon‐Cardo, C., & Prives, C. L. (2008) · Journal of Cell Science · doi:10.1242/jcs.030098 · Cited by 34
p53 localizes to intranucleolar regions distinct from the ribosome production compartments
Krüger, T., & Scheer, U. (2010) · Journal of Cell Science · doi:10.1242/jcs.062398 · Cited by 33
Jaafar, M., Paraqindes, H., Gabut, M., Diaz, J., Marcel, V., & Durand, S. (2021) · Cells · doi:10.3390/cells10081948 · Cited by 37
Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson
Menéndez, D., Inga, A., Jordan, J. J., & Resnick, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210277 · Cited by 32
Transcriptional responses to DNA damage
Silva, E., & Ideker, T. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.05.002 · Cited by 31
“In human cells, p53 represses the expression of ribosomal genes [31] and DNA damage limits the activity of RNA polymerase II by a combination of post-translational modifications and controlled degradation [32].”
PRIMA-1MET induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins
Rökaeus, N., Klein, G., Wiman, K. G., Székely, L., & Mattsson, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209858 · Cited by 31
Temaj, G., Chichiarelli, S., Telkoparan‐Akillilar, P., Saha, S., Nuhii, N., Hadžiselimović, R., & Saso, L. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116332 · Cited by 34
Rad9B responds to nucleolar stress through ATR and JNK signalling, and delays the G1–S transition
Perez-Castro, A., & Freire, R. (2012) · Journal of Cell Science · doi:10.1242/jcs.091124 · Cited by 30
Raychaudhuri, S., Fontanes, V., Barat, B., & Dasgupta, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3468 · Cited by 30
Ribosomal RNA Transcription Regulation in Breast Cancer
Harold, C. M., Buhagiar, A. F., Yan, C., & Baserga, S. J. (2021) · Genes · doi:10.3390/genes12040502 · Cited by 29
UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis
Gan, Y., Deng, J., Hao, Q., Huang, Y., Han, T., Xu, J.-G., Zhao, M., Yao, L., Xu, Y., Xiong, J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102705 · Cited by 31
Activation of RNA Polymerase I Transcription by Hepatitis C Virus Core Protein
Kao, C.-F., Chen, S.-Y., & Lee, Y. W. (2004) · Journal of Biomedical Science · doi:10.1007/bf02256551 · Cited by 29
Wisztorski, M., Aboulouard, S., Roussel, L., Duhamel, M., Saudemont, P., Cardon, T., Narducci, F., Robin, Y. M., Lemaire, A.-S., Bertin, D., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06165-5 · Cited by 28
Mechanism of RNA Polymerase I Transcription
Comai, L. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)67005-7 · Cited by 28
Self-citationWatt, K. E. N., Neben, C. L., Hall, S. M., Merrill, A. E., & Trainor, P. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy172 · Cited by 30
The RNA recognition motif of NIFK is required for rRNA maturation during cell cycle progression
Pan, W., Tsai, H., Wang, S., Hsiao, M., Wu, P., & Tsai, M. (2015) · RNA Biology · doi:10.1080/15476286.2015.1017221 · Cited by 28
p19 ARF and Ras V12 Offer Opposing Regulation of DHX33 Translation To Dictate Tumor Cell Fate
Zhang, Y., Saporita, A. J., & Weber, J. D. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01220-12 · Cited by 28
A mathematical model of vascular tumor treatment by chemotherapy
Liu, W., & Freedman, H. I. (2005) · Mathematical and Computer Modelling · doi:10.1016/j.mcm.2004.09.008 · Cited by 28
Regulation of RNA Polymerase I Stability and Function
Pitts, S. C., & Laiho, M. (2022) · Cancers · doi:10.3390/cancers14235776 · Cited by 33
Godefroy, N. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh773 · Cited by 27
Kermekchiev, M. B., & Ivanova, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8255-8263.2001 · Cited by 27
Decoding ribosome complexity: role of ribosomal proteins in cancer and disease
Fuentes, P. J. B., Pelletier, J., & Gentilella, A. (2024) · NAR Cancer · doi:10.1093/narcan/zcae032 · Cited by 29
Rothblum, K. N., Hu, Q., Penrod, Y., & Rothblum, L. I. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0229 · Cited by 26
POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients
Wang, M., Niu, W., Hu, R., Wang, Y., Liu, Y., Liu, L., Zhong, J., Zhang, C., You, H., Zhang, J., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22966 · Cited by 28
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer
Tsoi, H., You, C., Leung, M., Man, E. P. S., & Khoo, U. (2022) · Cancers · doi:10.3390/cancers14051251 · Cited by 26
SILAC analysis of oxidative stress‐mediated proteins in human pneumocytes: New role for treacle
Duan, X., Kelsen, S. G., Clarkson, A. B., Ji, R., & Merali, S. (2010) · PROTEOMICS · doi:10.1002/pmic.201000020 · Cited by 25
Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept
Donizy, P., Biecek, P., Hałoń, A., Maciejczyk, A., & Matkowski, R. (2017) · Diagnostic Pathology · doi:10.1186/s13000-017-0675-7 · Cited by 25
Kasteri, J., Das, D., Zhong, X., Persaud, L., Francis, A., Muharam, H., & Sauane, M. (2018) · Cancers · doi:10.3390/cancers10050133 · Cited by 24
Pantazi, A., Quintanilla, A., Hari, P., Tarrats, N., Parasyraki, E., Dix, F. L., Patel, J., Chandra, T., Acosta, J. C., & Finch, A. J. (2019) · Aging Cell · doi:10.1111/acel.12981 · Cited by 23
RNA polymerase III transcription is repressed in response to the tumour suppressor ARF
Morton, J. P., Kantidakis, T., & White, R. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm208 · Cited by 24
Derenzini, M., Montanaro, L., & Treré, D. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36627 · Cited by 22
ING1 regulates rRNA levels by altering nucleolar chromatin structure and mTOR localization
Rajarajacholan, U. K., Thalappilly, S., & Riabowol, K. T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1161 · Cited by 23
Identification of curcumin as a novel natural inhibitor of rDNA transcription
Xu, Y., Wu, Y., Wang, L., Qian, C., Wang, Q., & Wan, W. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1843817 · Cited by 21
Ponti, D., Bellenchi, G. C., Puca, R., Bastianelli, D., Maroder, M., Ragona, G., Roussel, P., Thiry, M., Mercola, D., & Calogero, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096037 · Cited by 21
BCR/ABL, mRNA translation and apoptosis
Perrotti, D., Turturro, F., & Neviani, P. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401606 · Cited by 21
Ponti, D., Bastianelli, D., Rosa, P., Pacini, L., Ibrahim, M., Rendina, E. A., Ragona, G., & Calogero, A. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0073-5 · Cited by 20
Andrews, W. J., Ray, S., Panova, T. B., Engel, C., & Panov, K. I. (2021) · Genes · doi:10.3390/genes12091412 · Cited by 20
Involvement of the transcriptional factor E2F1 in the regulation of the rRNA promoter
Ayrault, O., Andrique, L., & Seité, P. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.01.027 · Cited by 20
Nakade, K., Zheng, H., Ganguli, G., Buchwalter, G., Gross, C., & Wasylyk, B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1132-1142.2004 · Cited by 20
Hatanaka, M., Anderson‐Baucum, E. K., Lakhter, A. J., Kono, T., Maier, B., Tersey, S. A., Tanizawa, Y., Evans‐Molina, C., Mirmira, R. G., & Sims, E. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-03869-5 · Cited by 20
New roles for Dicer in the nucleolus and its relevance to cancer
Roche, B., Arcangioli, B., & Martienssen, R. A. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1361568 · Cited by 19
Nucleolar organization, growth control and cancer
Shiue, C.-N., Arabi, A., & Wright, A. P. H. (2010) · Epigenetics · doi:10.4161/epi.5.3.11376 · Cited by 18
Liu, H., Wang, J., Liu, Y., Hu, L., Zhang, C., Xing, B., & Du, X. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.08.016 · Cited by 17
Xu, H., Bionaz, M., Sloboda, D. M., Ehrlich, L., Li, S., Newnham, J. P., Dudenhausen, J. W., Henrich, W., Plagemann, A., Challis, J. R. G., et al. (2015) · BMC Research Notes · doi:10.1186/s13104-015-0973-7 · Cited by 16
Wang, C., Qin, S., Pan, W., Shi, X., Gao, H., Jin, P., Xia, X., & Ma, F. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.06.011 · Cited by 14
Scalia, P., Williams, S. J., Fujita‐Yamaguchi, Y., & Giordano, A. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2108117 · Cited by 17
TdIF2 is a nucleolar protein that promotes rRNA gene promoter activity
Koiwai, K., Noma, S., Takahashi, Y., Hayano, T., Maezawa, S., Kouda, K., Matsumoto, T., Suzuki, M., Furuichi, M., & Koiwai, O. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01524.x · Cited by 14
Justilien, V., Lewis, K. C., Meneses, K. M., Jamieson, L., Murray, N. R., & Fields, A. P. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013175 · Cited by 14
Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines
Oien, D. B., Ray, U., Pathoulas, C. L., Jin, L., Thirusangu, P., Jung, D., Kumka, J. E., Xiao, Y., Bhattacharya, S. S., Montoya, D. J., et al. (2021) · Cancers · doi:10.3390/cancers13184645 · Cited by 13
Screening E3 Substrates Using a Live Phage Display Library
Guo, Z., Wang, X., Li, H., & Gao, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076622 · Cited by 13
Structure and Function of Nopp140 and Treacle
He, F., & DiMario, P. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0514-6_11 · Cited by 13
Metadata
- Authors
- Zhai, W., & Comai, L.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Comai, Lucio
- ORCID
- Comai, Lucio
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2000-08
- Volume
- 20
- Issue
- 16
- Pages
- 5930-5938
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC86070
- OpenAlex
- W2146842824
- Cited by
- 289
- References
- 53
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 14 · 2020: 7 · 2019: 14 · 2018: 13 · 2017: 13 · 2016: 6 · 2015: 14 · 2014: 24 · 2013: 21 · 2012: 7
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM053949, R01 GM53949)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- p53, RNA polymerase I transcription, transcriptional repression, UBF, TATA-binding protein, protein-protein interaction, transcription initiation complex, tumor suppressor
- MeSH terms
- HeLa Cells, Humans, Plasmids, RNA Polymerase I, Transcription, Genetic, Transfection, Genes, Tumor Suppressor, Genes, p53, Tumor Suppressor Protein p53
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review